Publication | Open Access

Cost-Effectiveness of Second-Line Chemotherapy for Non-small Cell Lung Cancer: An Economic, Randomized, Prospective, Multicenter Phase III Trial Comparing Docetaxel and Pemetrexed: The GFPC 05-06 Study

OncologyGfpc 05-06 StudyHealth SciencesClinical TrialsPharmacotherapyCost EffectivenessCancer TreatmentMedicineRadiation OncologyLung CancerSecond-line Chemotherapy